Barinthus Biotherapeutics GAAP EPS of -$0.36 beats by $0.09

Published 1 day ago Positive
Barinthus Biotherapeutics GAAP EPS of -$0.36 beats by $0.09
* Barinthus Biotherapeutics press release [https://seekingalpha.com/pr/20298721-barinthus-bio-reports-third-quarter-2025-financial-results-and-updates-on-corporate] (BRNS [https://seekingalpha.com/symbol/BRNS]): Q3 GAAP EPS of -$0.36 beats by $0.09.
* Reported a net loss of $14.57M in Q3 2025 against a net loss of $8.1M in Q3 2024.

MORE ON BARINTHUS BIOTHERAPEUTICS

* Barinthus Biotherapeutics to combine with Clywedog Therapeutics [https://seekingalpha.com/news/4500169-barinthus-biotherapeutics-to-combine-with-clywedog-therapeutics]
* Seeking Alpha’s Quant Rating on Barinthus Biotherapeutics [https://seekingalpha.com/symbol/BRNS/ratings/quant-ratings]
* Historical earnings data for Barinthus Biotherapeutics [https://seekingalpha.com/symbol/BRNS/earnings]
* Financial information for Barinthus Biotherapeutics [https://seekingalpha.com/symbol/BRNS/income-statement]